147 related articles for article (PubMed ID: 2352597)
1. Neurotoxicity of local administration of two nitrosoureas in malignant gliomas.
Yamashima T; Yamashita J; Shoin K
Neurosurgery; 1990 May; 26(5):794-9. PubMed ID: 2352597
[TBL] [Abstract][Full Text] [Related]
2. Linkage between O6-methylguanine-DNA methyltransferase (O6-MT) activity and cellular resistance to antitumour nitrosoureas in cultured rat brain tumour cell strains.
Mineura K; Fushimi S; Kowada M; Isowa G; Ishizaki K; Ikenaga M
Acta Neurochir (Wien); 1990; 103(1-2):62-6. PubMed ID: 2360469
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxicity and pharmacokinetics of ventriculolumbar perfusion of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs.
Kochi M; Takaki S; Kuratsu J; Seto H; Kitamura I; Ushio Y
J Neurooncol; 1994; 19(3):239-44. PubMed ID: 7807174
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
Tonn JC; Schönmayr R; Kraemer HP
J Neurooncol; 1990 Feb; 8(1):41-5. PubMed ID: 2319289
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on anti-tumor effects of nitrosoureas, ACNU and MCNU, on experimental brain tumors (author's transl)].
Harada K; Kiya K; Okamoto H; Uozumi T
Neurol Med Chir (Tokyo); 1981 Oct; 21(10):1017-23. PubMed ID: 6172720
[No Abstract] [Full Text] [Related]
7. Diffuse low-density areas in white matter on CT scans after intracarotid ACNU infusion--report of three cases.
Sako K; Yonemasu Y; Okazaki S; Hodozuka A; Fujita T; Daita G; Takei H
Neurol Med Chir (Tokyo); 1990 Sep; 30(9):685-90. PubMed ID: 1708459
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic effects of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and radiation on the rat glioma (author's transl)].
Mineura K; Mori T; Katakura R; Sasaki T
No Shinkei Geka; 1981; 9(3):257-65. PubMed ID: 6941099
[No Abstract] [Full Text] [Related]
9. Sensitivity to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) of glioma cells in vivo and in vitro.
Yoshida J; Shibuya N; Kobayashi T; Kageyama N
Cancer; 1982 Aug; 50(3):410-8. PubMed ID: 6953989
[TBL] [Abstract][Full Text] [Related]
10. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
[TBL] [Abstract][Full Text] [Related]
11. Cross-resistance pattern in brain tumour cells resistant to antitumour chloroethylnitrosoureas.
Mineura K; Ishiyama Y; Kowada M
Neurol Res; 1992 Mar; 14(1):45-8. PubMed ID: 1351258
[TBL] [Abstract][Full Text] [Related]
12. [Anti-tumor activity of ACNU against malignant glioma--a clinical application of in vitro sensitivity test of chemotherapeutic agent].
Shibuya N; Yoshida J; Kobayashi T; Kageyama N
No Shinkei Geka; 1983 Apr; 11(4):361-7. PubMed ID: 6306497
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitro soureas and other nitrosoureas in beagles.
Levin VA; Byrd D; Campbell J; Giannini DD; Borcich JK; Davis RL
Cancer Res; 1985 Aug; 45(8):3803-9. PubMed ID: 3860287
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
Fujimoto S; Wang Y; Ogawa M
Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235
[TBL] [Abstract][Full Text] [Related]
15. Development of resistance to antitumor chloroethylnitrosoureas in vitro in brain tumor cells.
Mineura K; Ishiyama Y; Kowada M
Acta Oncol; 1992; 31(7):755-9. PubMed ID: 1476755
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
Ushio Y; Abe H; Suzuki J; Tanaka R; Kitamura K; Miwa T; Matsutani M; Takeuchi K; Takakura K; Nomura K
No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of MCNU for malignant brain tumors].
Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
[TBL] [Abstract][Full Text] [Related]
18. [Effects of phenobarbital on the metabolism of ACNU in vivo].
Nagashima T; Matsutani M; Kohono T
No To Shinkei; 1983 Jul; 35(7):677-82. PubMed ID: 6578801
[TBL] [Abstract][Full Text] [Related]
19. [ACNU delivery to malignant tumor tissue and serum--route of administration and combined use of phenobarbital].
Muraoka K
No To Shinkei; 1983 Dec; 35(12):1199-206. PubMed ID: 6584117
[TBL] [Abstract][Full Text] [Related]
20. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Kato T; Ota K
Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
